We are live on
!
Find out more
JCM
Jag Capital Management Portfolio holdings
AUM
$1.07B
1-Year Est. Return
60.59%
This Fund
S&P 500
This Quarter
Est. Return
+1.64%
1 Year Est. Return
+60.59%
3 Year Est. Return
+229.69%
5 Year Est. Return
+291.77%
10 Year Est. Return
+2,346.89%
AUM
$489M
AUM Growth
-$46.3M
(-8.7%)
Cap. Flow
-$34.1M
Cap. Flow
% of AUM
-6.98%
Top 10 Holdings %
Top 10 Hldgs %
31.37%
Holding
108
New
15
Increased
35
Reduced
40
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eaton
ETN
|
+$10.6M |
| 2 |
Darden Restaurants
DRI
|
+$9.98M |
| 3 |
Trane Technologies
TT
|
+$9.34M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$8.92M |
| 5 |
Tractor Supply
TSCO
|
+$7.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$18.7M |
| 2 |
Booking.com
BKNG
|
+$15.5M |
| 3 |
Monster Beverage
MNST
|
+$13.6M |
| 4 |
Gilead Sciences
GILD
|
+$12.6M |
| 5 |
Netflix
NFLX
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.65% |
| 2 | Consumer Discretionary | 16.88% |
| 3 | Industrials | 16.46% |
| 4 | Communication Services | 11.52% |
| 5 | Financials | 10.61% |
Similar funds
DCP
PP
ZIG
EC
SCM
HMH
BGIM
FNT
Jag Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, Jag Capital Management held 108 positions worth $489M, down 8.7% from $535M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Jag Capital Management withdrew a net $34.1M in Q1 2016, closing 9 positions and reducing 40 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $18.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jag Capital Management opened a new position in Eaton worth $12M.
- Jag Capital Management's largest Q1 2016 buy was Eaton: 192,408 shares worth $12M.
- Jag Capital Management added most to Intuitive Surgical in Q1 2016, an estimated $6.26M increase.
- Jag Capital Management's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $12.6M.
- Jag Capital Management fully exited Regeneron Pharmaceuticals in Q1 2016, selling an estimated $18.7M.
- Jag Capital Management's ten largest holdings make up 31% of its $489M portfolio in Q1 2016.
- Jag Capital Management opened 15 new positions and closed 9 in Q1 2016.
- Jag Capital Management's portfolio value fell 8.7% quarter-over-quarter to $489M.
Based on Jag Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.